Related references
Note: Only part of the references are listed.Ten-year employment patterns of patients with first-episode schizophrenia-spectrum disorders: comparison of early intervention and standard care services
Sherry Kit Wa Chan et al.
BRITISH JOURNAL OF PSYCHIATRY (2020)
Clinical indicators of treatment-resistant psychosis
Sophie E. Legge et al.
BRITISH JOURNAL OF PSYCHIATRY (2020)
Clozapine response trajectories and predictors of non-response in treatment-resistant schizophrenia: a chart review study
Parita Shah et al.
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2020)
Demographic and clinical features as predictors of clozapine response in patients with schizophrenia spectrum disorders: A systematic review and meta-analysis
C. Okhuijsen-Pfeifer et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2020)
Clozapine and Long-Term Mortality Risk in Patients With Schizophrenia: A Systematic Review and Meta-analysis of Studies Lasting 1.1-12.5 Years
Jentien M. Vermeulen et al.
SCHIZOPHRENIA BULLETIN (2019)
Predictive Factors of Treatment Resistance in First Episode of Psychosis: A Systematic Review
Paola Bozzatello et al.
FRONTIERS IN PSYCHIATRY (2019)
A systematic review of long-term outcomes of patients with psychosis who received early intervention services
Sherry Kit Wa Chan et al.
INTERNATIONAL REVIEW OF PSYCHIATRY (2019)
The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: A systematic review
Parita Shah et al.
PSYCHIATRY RESEARCH (2018)
Association of an Early Intervention Service for Psychosis With Suicide Rate Among Patients With First-Episode Schizophrenia-Spectrum Disorders
Sherry Kit Wa Chan et al.
JAMA PSYCHIATRY (2018)
Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis A Systematic Review, Meta-analysis, and Meta-regression
Christoph U. Correll et al.
JAMA PSYCHIATRY (2018)
Biological Predictors of Clozapine Response: A Systematic Review
Ruta Samanaite et al.
FRONTIERS IN PSYCHIATRY (2018)
Clozapine Use in a Cohort of First-Episode Psychosis
Roisin Doyle et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Antipsychotic treatment resistance in first-episode psychosis: prevalence, subtypes and predictors
A. Demjaha et al.
PSYCHOLOGICAL MEDICINE (2017)
Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia
Jari Tiihonen et al.
JAMA PSYCHIATRY (2017)
Clozapine Response Rates among People with Treatment-Resistant Schizophrenia: Data from a Systematic Review and Meta-Analysis
Dan Siskind et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2017)
The association between season of birth, age at onset, and clozapine use in schizophrenia
J. S. Kim et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D. Howes et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones
Felice Iasevoli et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Two distinct patterns of treatment resistance: clinical predictors of treatment resistance in first-episode schizophrenia spectrum psychoses
J. Lally et al.
PSYCHOLOGICAL MEDICINE (2016)
Impact of dopamine supersensitivity psychosis in treatment-resistant schizophrenia: An analysis of multi-factors predicting long-term prognosis
Hiroshi Yamanaka et al.
SCHIZOPHRENIA RESEARCH (2016)
Predictors of treatment resistance in patients with schizophrenia: a population-based cohort study
Theresa Wimberley et al.
LANCET PSYCHIATRY (2016)
10-year outcome study of an early intervention program for psychosis compared with standard care service
S. K. W. Chan et al.
PSYCHOLOGICAL MEDICINE (2015)
Clozapine: a review of clinical practice guidelines and prescribing trends
Stephanie Warnez et al.
BMC PSYCHIATRY (2014)
The social and economic burden of treatment-resistant schizophrenia: a systematic literature review
James L. Kennedy et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2014)
Three-factor model of premorbid adjustment in a sample with chronic schizophrenia and first-episode psychosis
Ana Barajas et al.
SCHIZOPHRENIA RESEARCH (2013)
Defining treatment-resistant schizophrenia and response to antipsychotics: A review and recommendation
Takefumi Suzuki et al.
PSYCHIATRY RESEARCH (2012)
Cross-national clinical and functional remission rates: Worldwide Schizophrenia Outpatient Health Outcomes (W-SOHO) study
Josep Maria Haro et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
Clozapine: dangerous orphan or neglected friend?
Saeed Farooq et al.
BRITISH JOURNAL OF PSYCHIATRY (2011)
International Consensus Study of Antipsychotic Dosing
David M. Gardner et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Early intervention for psychosis in Hong Kong - the EASY programme
Jennifer Y. M. Tang et al.
EARLY INTERVENTION IN PSYCHIATRY (2010)
Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages?
Michela Nose et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2008)
Premorbid functioning of patients with first-episode nonaffective psychosis: A comparison of deterioration in academic and social performance, and clinical correlates of Premorbid Adjustment Scale scores
Ralph C. Monte et al.
SCHIZOPHRENIA RESEARCH (2008)
Premorbid behavioral and intellectual functioning in schizophrenia patients with poor response to treatment with antipsychotic drugs
Asaf Caspi et al.
SCHIZOPHRENIA RESEARCH (2007)
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: Long-term treatment of schizophrenia
P Falkai et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2006)
Size of burden of schizophrenia and psychotic disorders
W Rössler et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2005)
Remission in schizophrenia: Proposed criteria and rationale for consensus
NC Andreasen et al.
AMERICAN JOURNAL OF PSYCHIATRY (2005)
The Clinical Global Impression-Schizophrenia scale:: a simple instrument to measure the diversity of symptoms present in schizophrenia
JM Haro et al.
ACTA PSYCHIATRICA SCANDINAVICA (2003)
Management of treatment resistance in schizophrenia
RR Conley et al.
BIOLOGICAL PSYCHIATRY (2001)
Share Paper
